2m 2m 2m 2m 2m 2m 2m
Inhibrx Bio (INBX)
NASDAQ
$86.94-$3.65 (-4.03%)
Price as of Nov 12, 2026 9:55 AM EST- $1.3BMarket Cap
- 23.55%1-Year Change
- BiotechnologyIndustry
Inhibrx Bio (INBX)
$86.94-$3.65 (-4.03%)
Earnings Score
Valuation | INBX | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | -0 | ||
Low Earnings Volatility | N/A |
Momentum Score
Valuation | INBX | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -5.74% | ||
12-Month Momentum | 11.87% | ||
3-Month Risk Adjusted Momentum | -19.77% | ||
12-Month Risk Adjusted Momentum | 15.81% |
True Yield
Valuation | INBX | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | -0.13% |
Financial Health Score
Valuation | INBX | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 1 |